0 results available. Select is focused ,type to refine list, press Down to open the menu,
Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology,...
The following section summarizes insights on Sandoz Group AG's Diluted EPS Growth:
We've identified the following companies as similar to Sandoz Group AG because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.
To view the full list of supported financial metrics please see Complete Metrics Listing.
Metrics similar to Diluted EPS Growth in the growth category include:
Period over prior period growth in diluted EPS.
The diluted eps incl extra items growth measures a company’s diluted eps incl extra items year-over-year growth.
Growth calculations are always made in the company’s reporting currency to ensure currency fluctuations do not impact the calculation. Sandoz’s reports in the USD currency. You can read more about Diluted EPS Incl Extra Items here.
The chart above depicts the distribution of diluted eps growth for companies operating in the Healthcare sector in the Developed economic region. Over 2,390 companies were considered in this analysis, and 2,301 had meaningful values. The average diluted eps growth of companies in the sector is 6.4% with a standard deviation of 115.1%.
Sandoz Group AG's Diluted EPS Growth of NM ranks in the - percentile for the sector. The following table provides additional summary stats:
| Economic Risk Region | Developed |
| Total Constituents | 2,396 |
| Included Constituents | 2,301 |
| Min | -767.9% |
| Max | 379.9% |
| Median | 23.2% |
| Mean | 6.4% |
| Standard Deviation | 115.1% |
You can find companies with similar diluted eps growth using this stock screener.